• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTICS PRODUCTS TSH REAGENT PACK; IN-VITRO DIAGNOSTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTICS PRODUCTS TSH REAGENT PACK; IN-VITRO DIAGNOSTICS Back to Search Results
Catalog Number 1912997
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/16/2021
Event Type  malfunction  
Manufacturer Narrative
The investigation determined that higher than expected thyroid stimulating hormone (tsh) results were obtained from a single patient sample using vitros immunodiagnostic products tsh reagent lot 6415 on a vitros 5600 integrated system.A definitive assignable cause could not be determined.Historical quality control results from the customers biorad qc for vitros tsh lot 6415 indicate imprecision at levels 2 and 3.However, the vitros tsh qc was within expectation on the day of the event, indicating acceptable vitros tsh lot 6415 reagent performance at that time.Ongoing tracking and trending of complaint data has not identified any signals to suggest there is a systemic quality issue with vitros tsh reagent lot 6415.A vitros tsh diagnostic precision test was not performed on the on the vitros 5600 system either at the time of the event or currently.A review of the vitros tsh qc using the customers current lot of vitros tsh (lot 6425) shows acceptable performance; however, the vitros tropi es diagnostic precision test indicated that there is a possible instrument issue and service actions were suggested to resolve.Therefore, an instrument issue cannot be fully ruled out as a contributor to the event.Pre-analytical sample processing could not be ruled out as a contributing factor as it is unknown if the customer was following the sample collection device manufacturer¿s recommended centrifugation protocol.Improper pre-analytical sample handling could have contributed to the event.It is possible that cellular debris, due to poor sample preparation, was present in the affected sample, although this could not be confirmed.A sample interferent was not able to be confirmed nor ruled out as a contributing factor of the event as no information was provided in regards to whether the patient was taking any medications or vitamin supplements around the time of the event.In addition, testing of the sample using heterophilic antibody blocking tubes was not performed.Email address for contact office (b)(4).
 
Event Description
The investigation determined that higher than expected thyroid stimulating hormone (tsh) results were obtained from a single patient sample using vitros immunodiagnostic products tsh reagent lot 6415 on a vitros 5600 integrated system.The results were higher than expected when compared to the result from a redraw sample from the patient obtained using an unknown chemiluminescent method.Patient sample vitros tsh results of 7.47 and 7.20 miu/l vs the expected result of 2.89 miu/l.Biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected.The higher than expected vitros tsh result was reported from the laboratory.However, a physician questioned the result and no treatment was initiated, altered or stopped based on the reported result.There is no allegation of patient harm as a result of this event.This report is number two of two 3500a forms filed for this event, as two devices were affected.This report corresponds to ortho clinical diagnostics inc (ortho) complaint number (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTICS PRODUCTS TSH REAGENT PACK
Type of Device
IN-VITRO DIAGNOSTICS
Manufacturer (Section G)
ORTHO CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend, wales CF35 5PZ
UK   CF35 5PZ
Manufacturer Contact
laurie o'riordan
1295 southwest 29th avenue
pompano beach, FL 33069
9549709500
MDR Report Key11957361
MDR Text Key266239905
Report Number3007111389-2021-00083
Device Sequence Number1
Product Code JLW
Combination Product (y/n)N
Reporter Country CodeBR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,o
Reporter Occupation Other
Type of Report Initial
Report Date 06/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/17/2021
Device Catalogue Number1912997
Device Lot Number6415
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 05/13/2021
Initial Date FDA Received06/08/2021
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/27/2020
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-